Adaptive Biotechnologies Corp (ADPT)
Healthcare
Diagnostics & Research
22.60 $
-6.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Adaptive Biotechnologies Corp (ADPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 641 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 718 | 661 | 620 | 585 | 559 | 539 | 511 | 497 | 491 | 513 | 506 | 641 | |
| 435 | 410 | 374 | 352 | 308 | 284 | 256 | 262 | 281 | 300 | 292 | 421 | |
| 89 | 65 | 71 | 60 | 38 | 48 | 51 | 43 | 55 | 70 | 78 | 170 | |
| 371 | 346 | 309 | 292 | 243 | 222 | 193 | 198 | 213 | 227 | 218 | 344 | |
| 31 | 38 | 42 | 36 | 41 | 42 | 44 | 44 | 46 | 50 | 48 | 50 | |
| 19 | 14 | 13 | 13 | 12 | 8.4 | 8.7 | 8.4 | 9.9 | 9.8 | 11 | 10 | |
| 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | |
| 5.6 | 5.1 | 4.7 | 4.3 | 3.9 | 3.4 | 3.0 | 2.6 | 2.2 | 1.7 | 1.3 | 0.9 | |
| 356 | 353 | 346 | 343 | 335 | 337 | 321 | 317 | 286 | 288 | 282 | 490 | |
| 93 | 88 | 83 | 88 | 88 | 98 | 88 | 92 | 83 | 90 | 87 | 88 | |
| 9.5 | 9.4 | 9.6 | 9.8 | 10 | 10 | 10 | 10.0 | 9.4 | 14 | 14 | 8.8 | |
| 4.5 | 7.7 | 12 | 9.9 | 7.4 | 7.3 | 6.4 | 6.9 | 10 | 6.5 | 9.6 | 5.2 | |
| 362 | 308 | 275 | 242 | 224 | 203 | 190 | 180 | 204 | 219 | 216 | 143 | |
| -1,075 | -1,144 | -1,192 | -1,238 | -1,270 | -1,304 | -1,334 | -1,359 | -1,350 | -1,363 | -1,383 | -1,423 | |
| 145 | 145 | 146 | 147 | 148 | 147 | 149 | 152 | 163 | 153 | 156 | 158 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.